Home / NATCOPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NATCOPHARM.NS make money? Does NATCOPHARM.NS have pricing power? What's the Earnings Whisper? Will NATCOPHARM.NS profit more as the business scales? What is NATCOPHARM.NS's management track record? Is NATCOPHARM.NS's current price justified?

NATCO Pharma Limited

₹785.05 -$103.15 (-11.61%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹784.95

Day Range

₹780.95₹788.5

Year Range

₹779₹1226.8

Market Cap

144.45B

AVG Volume

516.98K

Trailing/Forward PE

12.29/15.69

PEG ratio

-0.3

Dividend Yield

0.57%

Next Earnings Date

2026-11-17

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

NATCOPHARM.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	7.35B
26 Q4	7.39B
26 Q3	6.47B
26 Q2	13.63B
26 Q1	13.29B
25 Q4	12.23B
25 Q3	4.75B
25 Q2	13.71B
25 Q1	13.63B
24 Q4	10.71B

Net Income (INR) · Q

NATCOPHARM.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	2.06B
26 Q4	2.68B
26 Q3	1.51B
26 Q2	5.18B
26 Q1	4.81B
25 Q4	4.07B
25 Q3	1.33B
25 Q2	6.77B
25 Q1	6.68B
24 Q4	3.86B

Operating Income (INR) · Q

NATCOPHARM.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	1.39B
26 Q4	772M
26 Q3	1.12B
26 Q2	5.27B
26 Q1	5.13B
25 Q4	6.67B
25 Q3	2.5B
25 Q2	10.42B
25 Q1	10.4B
24 Q4	6.22B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

NATCO Pharma Limited

Video analysis: NATCOPHARM.NS

News: NATCOPHARM.NS

Similar companies